The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I trial sunitinib plus everolimus in patients with metastatic renal cell carcinoma (mRCC).
Ana M. Molina
No relevant relationships to disclose
Darren Richard Feldman
No relevant relationships to disclose
Michelle S. Ginsberg
No relevant relationships to disclose
Patricia Fischer
No relevant relationships to disclose
Michael J. Trinos
No relevant relationships to disclose
Sujata Patil
No relevant relationships to disclose
Robert John Motzer
No relevant relationships to disclose